Biocryst Pharmaceuticals Inc (BCRX)

10:22 AM

BioCryst's Booming HAE Drug Sales Set The Stage For A Strong 2025Will The Stock Follow? - RTTNews

10:22 AM

Mar 19, 2025

North Carolina biotech sues to block copies of $400M drug - Triangle Business Journal

Mar 19, 2025

Mar 18, 2025

Institutional investors control 75% of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and were rewarded last week after stock increased 4.9% - Yahoo Finance

Mar 18, 2025

Mar 18, 2025

Groundbreaking Step in Battling Angioedema at UC San Diego - University of California San Diego

Mar 18, 2025

Mar 18, 2025

The 4.9% return this week takes BioCryst Pharmaceuticals' (NASDAQ:BCRX) shareholders five-year gains to 295% - Simply Wall St

Mar 18, 2025

Mar 14, 2025

(BCRX) Technical Data - Stock Traders Daily

Mar 14, 2025

Mar 14, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Mar 14, 2025

Mar 13, 2025

25,583 Shares in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Bought by Proficio Capital Partners LLC - Defense World

Mar 13, 2025

Mar 13, 2025

BioCryst’s SWOT analysis: orladeyo success fuels growth amid competition By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 12, 2025

BioCryst’s SWOT analysis: orladeyo success fuels growth amid competition - Investing.com

Mar 12, 2025

Mar 11, 2025

BioCryst at Barclays Conference: Strategic Growth and Pipeline Focus By Investing.com - Investing.com Canada

Mar 11, 2025

Mar 11, 2025

BioCryst sues to protect ORLADEYO patents By Investing.com - Investing.com Canada

Mar 11, 2025

Mar 11, 2025

BioCryst Sues Hetero to Block Copies of Drug Worth $386 Million - Bloomberg Law

Mar 11, 2025

Mar 11, 2025

BioCryst takes legal action to defend rare genetic drug patent; shares fall - TradingView

Mar 11, 2025

Mar 11, 2025

BioCryst sues to protect ORLADEYO patents - Investing.com India

Mar 11, 2025

Mar 11, 2025

Biocryst PharmaceuticalsOn March 10, Files Patent Infringement Lawsuit Against Annora And Other Co's - Marketscreener.com

Mar 11, 2025

Mar 09, 2025

Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX) - GuruFocus.com

Mar 09, 2025

Mar 09, 2025

Principal Financial Group Inc. Sells 393,607 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Mar 09, 2025

Mar 06, 2025

Orladeyo safely prevents swelling attacks in young children with HAE - Angioedema News Today

Mar 06, 2025

Mar 06, 2025

BioCryst at TD Cowen Conference: Strategic Growth Insights - Investing.com

Mar 06, 2025

Mar 06, 2025

BioCryst at TD Cowen Conference: Strategic Growth Insights By Investing.com - Investing.com UK

Mar 06, 2025

Mar 06, 2025

BioCryst Pharmaceuticals Inc (BCRX) Announces Grant of Restricted Stock Units to New Employees - GuruFocus.com

Mar 06, 2025

Mar 06, 2025

BioCryst reports inducement grants under Nasdaq listing rule - TipRanks

Mar 06, 2025

Mar 06, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 06, 2025

Mar 06, 2025

BioCryst's Latest Employee Stock Awards: Key Details on 65,900 RSU Grants - StockTitan

Mar 06, 2025

Mar 06, 2025

BioCryst CFO resigns, search for successor begins By Investing.com - Investing.com Australia

Mar 06, 2025

Mar 04, 2025

CFO Anthony Doyle resigns at Biocryst - BioCentury

Mar 04, 2025

Mar 04, 2025

BioCryst CFO resigns, search for successor begins - Investing.com India

Mar 04, 2025

Mar 04, 2025

BioCryst CFO Anthony Doyle Resigns Effective April 2025 - TipRanks

Mar 04, 2025

Mar 04, 2025

Where are the Opportunities in (BCRX) - Stock Traders Daily

Mar 04, 2025

Mar 03, 2025

Rhumbline Advisers Has $2.33 Million Stock Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Mar 03, 2025

Mar 03, 2025

BioCryst stock holds $18 target, JMP bullish on trial results By Investing.com - Investing.com Canada

Mar 03, 2025

Mar 01, 2025

Is BioCryst Pharmaceuticals, Inc. (BCRX) the Best Small-Cap Stock to Buy Now? - MSN

Mar 01, 2025

Feb 28, 2025

Here's Why BioCryst (BCRX) Could be Great Choice for a Bottom Fisher - MSN

Feb 28, 2025

Feb 28, 2025

10 Best Small-Cap Stocks to Buy Now - Insider Monkey

Feb 28, 2025

Feb 28, 2025

BioCryst Pharmaceuticals' (BCRX) "Outperform" Rating Reaffirmed at Royal Bank of Canada - MarketBeat

Feb 28, 2025

Feb 28, 2025

Wedbush Initiates Coverage on BioCryst Pharmaceuticals (NASDAQ:BCRX) - MarketBeat

Feb 28, 2025

Feb 28, 2025

HC Wainwright Reiterates Buy Rating for BioCryst Pharmaceuticals (NASDAQ:BCRX) - MarketBeat

Feb 28, 2025

Feb 28, 2025

Analysts Set Expectations for BCRX Q1 Earnings - Defense World

Feb 28, 2025

Feb 27, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Issues Earnings Results - MarketBeat

Feb 27, 2025

Feb 27, 2025

BioCryst stock soars to 52-week high, touches $9.02 - MSN

Feb 27, 2025

Feb 27, 2025

BioCryst (BCRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Feb 27, 2025

Feb 27, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Down Following Weak Earnings - MarketBeat

Feb 27, 2025

Feb 26, 2025

Wall Street Analysts Predict an 84.18% Upside in BioCryst (BCRX): Here's What You Should Know - MSN

Feb 26, 2025